T M Morris - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

T M Morris

Showing results (11-20 of 33) with videos related to

Pageof 4

Sort By:

Acta Radiologica (Stockholm, Sweden : 1987)|July 1, 1989

Opening of the blood-brain barrier by intravenous contrast media in euvolemic and dehydrated rabbitsK Hayakawa, T M Morris, R W Katzberg

British Journal of Cancer|June 13, 2001

Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-1-matrix metalloproteinaseH M Collins, T M Morris, S A Watson

Journal of Cancer Research and Clinical Oncology|January 1, 1991

Influence of recombinant tumour necrosis factor alpha on blood flow and antibody localisation in human tumour xenografts in nude miceM V Pimm, S J Gribben, T M Morris

Cancer Research|November 4, 2000

Antiserum raised against an epitope of the cholecystokinin B/gastrin receptor inhibits hepatic invasion of a human colon tumorS A Watson, P A Clarke, T M Morris, et al.

European Journal of Cancer (Oxford, England : 1990)|January 1, 1993

A hepatic invasive human colorectal xenograft modelS A Watson, T M Morris, D M Crosbee, et al.

Gut|November 24, 1999

A comparison of the therapeutic effectiveness of gastrin neutralisation in two human gastric cancer models: relation to endocrine and autocrine/paracrine gastrin mediated growthS A Watson, T M Morris, A Varro, et al.

British Journal of Cancer|November 1, 1996

Therapeutic effect of the matrix metalloproteinase inhibitor, batimastat, in a human colorectal cancer ascites modelS A Watson, T M Morris, S L Parsons, et al.

European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 5, 2005

Inhibition of matrix metalloproteinase activity and growth of gastric adenocarcinoma cells by an angiotensin converting enzyme inhibitor in in vitro and murine modelsR N Williams, S L Parsons, T M Morris, et al.

Cancer Research|March 30, 1999

A novel, orally administered nucleoside analogue, OGT 719, inhibits the liver invasive growth of a human colorectal tumor, C170HM2C Rohlff, S A Watson, T M Morris, et al.

British Journal of Cancer|September 16, 1999

Inhibition of tumour growth by marimastat in a human xenograft model of gastric cancer: relationship with levels of circulating CEAS A Watson, T M Morris, H M Collins, et al.

Pageof 4

Search research articles

Showing results (11-20 of 33) with videos related to

Sort By:

Pageof 4

Acta Radiologica (Stockholm, Sweden : 1987)|July 1, 1989

Opening of the blood-brain barrier by intravenous contrast media in euvolemic and dehydrated rabbitsK Hayakawa, T M Morris, R W Katzberg

British Journal of Cancer|June 13, 2001

Journal of Cancer Research and Clinical Oncology|January 1, 1991

Influence of recombinant tumour necrosis factor alpha on blood flow and antibody localisation in human tumour xenografts in nude miceM V Pimm, S J Gribben, T M Morris

Cancer Research|November 4, 2000

Antiserum raised against an epitope of the cholecystokinin B/gastrin receptor inhibits hepatic invasion of a human colon tumorS A Watson, P A Clarke, T M Morris, et al.

European Journal of Cancer (Oxford, England : 1990)|January 1, 1993

A hepatic invasive human colorectal xenograft modelS A Watson, T M Morris, D M Crosbee, et al.

Gut|November 24, 1999

British Journal of Cancer|November 1, 1996

Therapeutic effect of the matrix metalloproteinase inhibitor, batimastat, in a human colorectal cancer ascites modelS A Watson, T M Morris, S L Parsons, et al.

European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 5, 2005

Cancer Research|March 30, 1999

A novel, orally administered nucleoside analogue, OGT 719, inhibits the liver invasive growth of a human colorectal tumor, C170HM2C Rohlff, S A Watson, T M Morris, et al.

British Journal of Cancer|September 16, 1999

Inhibition of tumour growth by marimastat in a human xenograft model of gastric cancer: relationship with levels of circulating CEAS A Watson, T M Morris, H M Collins, et al.

Pageof 4